President Bush issued Executive Order 13462 last week redesignating the President’s Foreign Intelligence Advisory Board (PFIAB) as the President’s Intelligence Advisory Board (PIAB), and modifying the Board’s functions and interactions with the executive branch.
The Order appeared to diminish the Board’s autonomy and to further reduce its influence, which has been negligible in recent years.
It was reported by Pamela Hess of the Associated Press in “New White House Order Bolsters Intelligence Chief’s Power,” February 29.
The new Order and the 1993 Order that it superseded were critically compared by Smintheus in Daily Kos.
The absence of consistent voting privileges for patient representatives on Advisory Committees hinders representatives from providing an voice on behalf of the community they represent.
Grant funds research of AI’s impact on nuclear weapons, biosecurity, military autonomy, cybersecurity, and other global issues.
AdComm members note a lack of transparency in recruitment methods, insufficient training, and limited understanding of regulatory procedures.
Internal disagreements present a growing concern about FDA leadership overruling the expert opinions of scientific staff and proceeding with official approvals, thus undermining staff expertise, decreasing agency morale, and potentially diminishing public trust.